Although there has been limited research into its role in the intestinal tract, TFF1 is observed to increase at sites of intestinal inflammation, such as in patients with active IBD, and in some non-intestinal inflammatory conditions, such as pancreatitis [45,46,47,48]. This evidence concerns the gene TFF1 and inflammatory bowel disease.